Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Maintaining momentum mid month requires steady approaches. Discover ways to keep your budget on track mid month and stay aligned with goals.
25,694 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A new ranking highlights 33 U.S. rifle makers that produced the most rifles in 2022, underscoring domestic manufactur...
Bitcoin climbed toward the $70,000 mark as oil prices slid on indications that Middle East tensions might ease. Trade...
Texas is rapidly becoming the leading destination for AI data centers as cloud providers expand across the state. Ene...
Fresh insider purchases in three battered names point to growing belief that cash flow and demand visibility can rebo...
Ethereum climbed above $2,300 in today's session but faces a tough hurdle at the $2,400 zone. This ethereum price ana...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
Trump crypto price test unfolds as the token hovers near key support while volume sinks, signaling uncertain convicti...
JPMorgan downgraded Wix.com to Underweight and cut its price target to $91, citing slower core growth and volatile ma...
A new wave of fiber-infused sodas and gummies is hitting shelves as 'fibermaxxing' spurred a fiber push across snacks...
Figma stock shows signs of a potential rebound as profitability improves and AI-driven features gain traction, even a...
Strategy unveiled a plan to repurchase roughly $1.5 billion of its 2029 notes, with funding options including Bitcoin...